Dna X Inc (SONM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 0 | 15,022 | 11,516 | 16,776 | 13,430 |
| Cost of Goods | -33,211 | 10,790 | 8,547 | 13,874 | 8,310 |
| Gross Profit | -10,103 | 4,232 | 2,969 | 2,902 | 5,120 |
| Operating Expenses | -18,749 | 7,398 | 9,986 | 6,465 | 6,685 |
| Operating Income | 8,435 | -2,376 | -6,470 | -2,689 | -1,255 |
| Interest Expense | 12 | 0 | 17 | 0 | 4 |
| Other Income | 449 | -19 | -92 | -92 | -1 |
| Pre-tax Income | 8,872 | -2,395 | -6,579 | -2,781 | -1,260 |
| Income Tax | N/A | 117 | 37 | 125 | 93 |
| Net Income Continuous | 9,151 | -2,512 | -6,616 | -2,906 | -1,353 |
| Net Income | $-21,614 | $-2,512 | $-6,616 | $-2,906 | $-1,353 |
| EPS Basic Total Ops | -82.00 | -9.32 | -25.36 | -11.69 | -6.47 |
| EPS Basic Continuous Ops | 35.50 | -9.32 | -25.40 | -11.78 | -5.75 |
| EPS Diluted Total Ops | -82.00 | -9.32 | -25.36 | -11.69 | -6.30 |
| EPS Diluted Continuous Ops | 35.50 | -9.32 | -25.40 | -11.78 | -5.57 |
| EPS Diluted Before Non-Recurring Items | N/A | -9.35 | -25.36 | -12.59 | N/A |
| EBITDA(a) | $52,663 | $-1,458 | $-5,625 | $-1,809 | $-299 |